Kevin Heal is ranked #1393 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Kevin Heal (Argus Research) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Kevin Heal's stock ratings?

About 57% of Kevin's ratings were profitable over a one-year hold, with an average return of +1.9% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/Kevin Heal

ARG

Kevin Heal

Argus Research

Wall Street Analyst

★★★☆☆

#1393

on 13Foresight · ranked by our own returns

57%

Success Rate

+2.0%

Average Return

21 of 37 calls profitable · -11.3% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 57% of Kevin Heal's ratings turned a profit when each position was held for 1 year — averaging +2.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

33 Buy 11 Hold 0 Sell

Kevin's Stock Coverage 34 ratings · 2026-06-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
TSE:SLF Sun Life Financial	Jun 09, 2026	BUY	Buy -10.6% avg upside 17 analysts	$114.72 4.92% Upside	·
PRU Prudential Financial	Jun 08, 2026	HOLD	Hold -5.2% avg upside 29 analysts	$103.72 2.56% Downside	-0.0%
BRK.B Berkshire Hathaway B	Jun 04, 2026	BUY	Buy -15.4% avg upside 9 analysts	—	·
MKL Markel	Jun 03, 2026	HOLD	Buy -5.5% avg upside 10 analysts	—	+5.1%
ICE Intercontinental Exchange	May 28, 2026	BUY	Strong Buy +35.6% avg upside 24 analysts	$190.00 41.83% Upside	-8.9%
ALL Allstate	May 27, 2026	BUY	Buy -9.6% avg upside 34 analysts	$238.00 7.55% Upside	+5.1%
SPGI S&P Global	May 21, 2026	BUY	Strong Buy +23.0% avg upside 33 analysts	—	+0.8%
RITM Rithm Capital	May 08, 2026	BUY	Strong Buy +41.4% avg upside 16 analysts	$12.00 30.58% Upside	-5.8%
CB Chubb	Apr 27, 2026	BUY	Buy -6.1% avg upside 32 analysts	$360.00 11.22% Upside	+0.5%
MSCI MSCI	Apr 23, 2026	BUY	Strong Buy +5.2% avg upside 26 analysts	$660.00 13.46% Upside	+0.2%
ZION Zions Bancorporation National Association	Apr 21, 2026	BUY	Hold -6.6% avg upside 34 analysts	$70.00 5.76% Upside	+7.5%
RF Regions Financial	Apr 20, 2026	BUY	Buy -2.4% avg upside 32 analysts	$31.00 8.34% Upside	+2.2%
TRV Travelers Companies	Apr 17, 2026	BUY	Hold -7.1% avg upside 32 analysts	$330.00 7.24% Upside	+2.4%
UWMC UWM Holding	Mar 30, 2026	HOLD	Buy +170.6% avg upside 18 analysts	$3.47 56.39% Upside	-33.1%
COIN Coinbase Global	Mar 23, 2026	HOLD	Buy +59.9% avg upside 43 analysts	—	-18.6%
MKTX Marketaxess Holdings	Mar 17, 2026	HOLD	Buy +50.9% avg upside 15 analysts	—	-29.9%
CME CME Group	Mar 03, 2026	HOLD	Buy +12.3% avg upside 24 analysts	—	-20.1%
CFG Citizens Financial	Jan 22, 2026	BUY	Strong Buy +0.6% avg upside 25 analysts	$72.00 7.37% Upside	+6.2%
MET Metlife	Dec 08, 2025	BUY	Strong Buy -2.5% avg upside 31 analysts	$90.00 5.21% Upside	+11.6%
HIG Hartford Insurance	Nov 24, 2025	BUY	Buy +0.4% avg upside 31 analysts	$155.00 20.85% Upside	-3.8%
BHF Brighthouse Financial	Sep 02, 2025	HOLD	Hold -3.3% avg upside 20 analysts	—	+37.0%
AIG American International Group	Aug 20, 2025	BUY	Buy +12.8% avg upside 32 analysts	$90.00 21.67% Upside	-6.7%
AJG Arthur J Gallagher & Co	Aug 08, 2025	BUY	Strong Buy +20.4% avg upside 30 analysts	$330.00 54.10% Upside	-23.8%
PGR Progressive	Aug 08, 2025	HOLD	Buy +8.8% avg upside 29 analysts	—	-11.7%
RJF Raymond James Financial	Jul 25, 2025	BUY	Buy +8.8% avg upside 17 analysts	$185.00 18.73% Upside	-6.5%
MCO Moody's	Jul 23, 2025	BUY	Strong Buy +10.3% avg upside 31 analysts	$550.00 21.99% Upside	-10.5%
AMP Ameriprise Financial	May 05, 2025	BUY	Buy +5.3% avg upside 18 analysts	—	+0.0%
AGNC AGNC Investment	Apr 29, 2025	HOLD	Buy +23.1% avg upside 19 analysts	—	+39.7%
HBAN Huntington Bancshares	Apr 25, 2025	BUY	Strong Buy +10.8% avg upside 27 analysts	$17.00 0.76% Upside	+18.3%
RKT Rocket Companies	Mar 24, 2025	HOLD	Buy +26.4% avg upside 26 analysts	—	+3.0%
NDAQ Nasdaq	Feb 10, 2025	BUY	Strong Buy +15.9% avg upside 25 analysts	$88.00 6.96% Upside	+2.9%
NLY Annaly Capital	Feb 04, 2025	BUY	Strong Buy +3.3% avg upside 19 analysts	—	+28.8%
ETR Entergy	Aug 27, 2024	BUY	Strong Buy +1.3% avg upside 29 analysts	—	+54.9%
CBOE Cboe Global Markets	Nov 16, 2023	HOLD	Hold +2.9% avg upside 24 analysts	—	+14.3%

🔒 29 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Kevin Heal — Frequently Asked Questions

How accurate are Kevin Heal's stock ratings?

Based on the calls 13Foresight could measure, about 57% of Kevin's ratings were profitable over a one-year hold, with an average return of +1.9% per rating, or -11.2% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Kevin ranked on 13Foresight?

Kevin Heal is currently ranked #1393 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Kevin cover?

Kevin most recently has ratings on TSE:SLF, PRU, BRK.B, MKL, ICE, ALL, SPGI, RITM, CB, MSCI, ZION, RF and 22 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!